Wegovy is now positioned as the first and only GLP-1 treatment.

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...

FDA states substantial evidence of efficacy was not demonstrated.

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...

In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.

Anocca AB ( Anocca ), a clinical-stage T-cell immunotherapy company, raised SEK ~440 million (USD ~46 million) in financing. Mellby Gård led the financing with strong support from AMF, Ramsbury, and ...

Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.

Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the ...

Envirotainer, a provider of secure cold chain solutions for temperature-sensitive pharmaceuticals, has invested in Swiss ...

Platform and product releases span OPUS, MINT, POET, and SPI.

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...